Plasma levels of glucagon but not GLP-1 are elevated in response to inflammation in humans
Objective: Glucagon and glucagon-like peptide-1 (GLP-1) originate from the common precursor, proglucagon, and their plasma concentrations have been reported to be increased during inflammatory conditions. Increased blood glucose levels are frequently observed in septic patients, and therefore we hyp...
Principais autores: | Justyna Modrzynska, Christine F Klein, Kasper Iversen, Henning Bundgaard, Bolette Hartmann, Maike Mose, Nikolaj Rittig, Niels Møller, Jens J Holst, Nicolai J Wewer Albrechtsen |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Bioscientifica
2021-03-01
|
coleção: | Endocrine Connections |
Assuntos: | |
Acesso em linha: | https://ec.bioscientifica.com/view/journals/ec/10/2/EC-20-0590.xml |
Registros relacionados
-
Glucagon Receptor Signaling and Lipid Metabolism
por: Katrine D. Galsgaard, et al.
Publicado em: (2019-04-01) -
Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion
por: Nicolai J. Wewer Albrechtsen, et al.
Publicado em: (2016-01-01) -
Prolonged lipopolysaccharide‐induced illness elevates glucagon‐like peptide‐1 and suppresses peptide YY: A human‐randomized cross‐over trial
por: Katrine Brodersen, et al.
Publicado em: (2022-09-01) -
Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
por: Dorte B. Zilstorff, et al.
Publicado em: (2024-03-01) -
Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors
por: Jonas Ronn, et al.
Publicado em: (2017-12-01)